VELIGROTUG
UNII Z9U2SS9ZC8

Substance Identification & Data

This profile provides standardized clinical and technical data for Veligrotug, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Z9U2SS9ZC8.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2728655-31-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
Z9U2SS9ZC8
CAS Registry Number
2728655-31-8
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
VELIGROTUG
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
12548
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
MN-133
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Veligrotug. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

VELIGROTUG

Common Names & Synonyms

ANTI-CD122 MONOCLONAL ANTIBODY AVE1642
ANTI-IGF-1R MONOCLONAL ANTIBODY AVE1642
HUMANISED IGG1 KAPPA ANTI-INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR MONOCLONAL ANTIBODY VRDN-001
IMMUNOGLOBULIN G1, ANTI-(HUMAN INSULIN-LIKE GROWTH FACTOR I RECEPTOR) (HUMAN-MUS MUSCULUS MONOCLONAL VRDN-001 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL VRDN-001 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IGF1R (INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR, IGF1-R, IGF-1R, CD221)), CHIMERIC MONOCLONAL ANTIBODY (GAMMA1 HEAVY CHAIN CHIMERIC (1-454) (VH (MUS MUSCULUS IGHV1S81*02 (91.8%) -(IGHD) -IGHJ1*01 (93.8%), CDR-IMGT (8.8.17) (26-33.51-58.97-113)) (1-124) -HOMO SAPIENS IGHG1*01 (100%), G1M17,1 CH1 K120, D12, L14 (CH1 K120 (221) (125-222), HINGE 1-15 (223-237), CH2 (238-347), CH3 D12 (363), L14(365) (348-452), CHS (453-454)) (125-454)), (227-219')-DISULFIDE WITH KAPPA LIGHT CHAIN CHIMERIC (1'-219')(V-KAPPA (MUS MUSCULUS IGKV1-117*01 (93.0%) -IGKJ1*02 (100%), CDR-IMGT (11.3.9) (27-37.55-57.94-102)) (1'-112') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (158), V101 (196) (113'-219')); DIMER (233-233'':236-236'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, DERIVED FROM THE CELL LINE CHO-K1, GLYCOFORM ALFA)
VELIGROTUG [INN]
VELIGROTUG [USAN]
VELIGROTUG [WHO-DD]

Technical Codes

AVE1642
AVE-1642